Skip to main content

Peer Review reports

From: Lower hypoglycemic but higher antiatherogenic effects of bitter melon than glibenclamide in type 2 diabetic patients

Original Submission
21 Aug 2014 Submitted Original manuscript
Author responded Author comments
Reviewed Reviewer Report
Reviewed Reviewer Report
Reviewed Reviewer Report
Resubmission - Version 2
Submitted Manuscript version 2
Reviewed Reviewer Report
Resubmission - Version 3
Submitted Manuscript version 3
Publishing
8 Jan 2015 Editorially accepted
26 Jan 2015 Article published 10.1186/1475-2891-14-13

You can find further information about peer review here.

Back to article page